XML 71 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Reporting - Segment Results (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Segment Reporting [Abstract]      
Revenues $ 4,910.2 $ 2,451.9 $ 2,689.8
Adjusted EBITDA 1,130.7 604.2 702.1
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]      
Interest expense 111.1 88.9 99.6
Impairment of other intangible assets 19.9 0.0 0.0
Restructuring and related business transformation costs 97.9 25.6 38.8
Acquisition related expenses and non-cash charges 97.3 53.8 9.8
Stock-based compensation 51.3 19.2 2.8
Loss on extinguishment of debt 2.0 0.2 1.1
Foreign currency transaction losses (gains), net 20.9 8.1 (1.9)
Shareholder litigation settlement recoveries 0.0 (6.0) (9.5)
Income (Loss) Before Income Taxes (19.4) 190.9 349.5
Insurance recoveries of legal defense costs     8.2
Depreciation of rental equipment 8.0    
Restructuring Costs [Abstract]      
Restructuring charges 92.9 17.1 12.7
Severance, sign-on, relocation and executive search costs 2.8 2.5 4.1
Facility reorganization, relocation and other costs 2.1 2.4 3.1
Information technology infrastructure transformation 0.0 1.2 0.8
Losses (gains) on asset and business disposals 0.0 0.8 (1.1)
Consultant and other advisor fees 0.0 0.3 14.1
Other, net 0.1 1.3 5.1
Total restructuring and related business transformation costs 97.9 25.6 38.8
Stock-based compensation expense recognized 51.3 19.2 2.8
Stock-based compensation expense related to stock option exercise (0.5)    
Decrease in stock-based compensation expense to DSU's   1.5  
Total identifiable assets 16,058.6 4,628.4 4,487.1
Total capital expenditures 48.7 43.2 52.2
2013 Stock Incentive Plan      
Restructuring Costs [Abstract]      
Stock-based compensation expense recognized     3.8
2013 Stock Incentive Plan | Stock Options      
Restructuring Costs [Abstract]      
Stock-based compensation expense recognized     2.8
2013 Stock Incentive Plan | Deferred Stock Units      
Restructuring Costs [Abstract]      
Tax benefit related to DSUs granted     (5.6)
Industrial Technologies and Services      
Segment Reporting [Abstract]      
Revenues 3,248.2 1,700.9  
Precision and Science Technologies      
Segment Reporting [Abstract]      
Revenues 725.0 316.6  
Specialty Vehicle Technologies      
Segment Reporting [Abstract]      
Revenues 741.4 0.0  
High Pressure Solutions      
Segment Reporting [Abstract]      
Revenues 195.6 434.4  
Operating segments      
Restructuring Costs [Abstract]      
Total identifiable assets 14,299.9 4,101.6 4,258.9
Operating segments | Industrial Technologies and Services      
Segment Reporting [Abstract]      
Revenues 3,248.2 1,700.9 1,739.6
Adjusted EBITDA 759.8 391.4 393.6
Restructuring Costs [Abstract]      
Total identifiable assets 9,113.4    
Depreciation and amortization expense 314.3 123.9 128.3
Total capital expenditures 32.2 31.5 35.3
Operating segments | Precision and Science Technologies      
Segment Reporting [Abstract]      
Revenues 725.0 316.6 280.2
Adjusted EBITDA 220.2 95.8 80.7
Restructuring Costs [Abstract]      
Total identifiable assets 2,852.8    
Depreciation and amortization expense 106.3 26.2 23.9
Total capital expenditures 9.8 5.5 4.9
Operating segments | Specialty Vehicle Technologies      
Segment Reporting [Abstract]      
Revenues 741.4 0.0 0.0
Adjusted EBITDA 138.6 0.0 0.0
Restructuring Costs [Abstract]      
Total identifiable assets 1,645.9 0.0 0.0
Depreciation and amortization expense 53.5 0.0 0.0
Total capital expenditures 2.9 0.0 0.0
Operating segments | High Pressure Solutions      
Segment Reporting [Abstract]      
Revenues 195.6 434.4 670.0
Adjusted EBITDA 12.1 117.0 227.8
Restructuring Costs [Abstract]      
Total identifiable assets 687.8    
Depreciation and amortization expense 26.8 28.0 28.2
Total capital expenditures 3.8 6.2 12.0
Operating segments | Industrials      
Restructuring Costs [Abstract]      
Total identifiable assets   2,729.7 2,806.6
Operating segments | Energy      
Restructuring Costs [Abstract]      
Total identifiable assets   558.4 570.0
Operating segments | Medical      
Restructuring Costs [Abstract]      
Total identifiable assets   813.5 882.3
Corporate expenses not allocated to segments      
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]      
Operating Expenses 113.1 42.5 18.7
Restructuring Costs [Abstract]      
Total identifiable assets 1,758.7 526.8 228.2
Segment reconciling items      
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes [Abstract]      
Interest expense 111.1 88.9 99.6
Depreciation, Depletion and Amortization, Excluding Rental Equipment Depreciation 492.9 178.1 180.4
Impairment of other intangible assets 19.9 0.0 0.0
Restructuring and related business transformation costs 97.9 25.6 38.8
Acquisition related expenses and non-cash charges 233.2 54.6 16.7
Expenses related to public stock offerings 0.0 0.0 2.9
Establish public company financial reporting compliance 0.0 0.6 4.3
Stock-based compensation 50.8 20.7 (2.8)
Loss on extinguishment of debt 2.0 0.2 1.1
Foreign currency transaction losses (gains), net 20.9 8.1 (1.9)
Shareholder litigation settlement recoveries 0.0 (6.0) (9.5)
Other adjustments 8.3 0.0 4.3
Restructuring Costs [Abstract]      
Total restructuring and related business transformation costs 97.9 25.6 38.8
Depreciation and amortization expense $ 500.9 $ 178.1 $ 180.4